马来酸依那普利是新型的第二代长效血管紧张素转化酶抑制剂ACEI，主要通过减少血管紧张素的产生．削弱血管机制和减少醛固酮的钢水能留而达到降血压的目的。本文对43例原发性高血压病人运用依那普利胶囊进行治疗．观察和探讨依那普利治疗原发性高血压的临床疗效及不良反应，介? Enalapril maleate is the new second-generation ACEI that is a long-acting angiotensin-converting enzyme inhibitor, mainly through the reduction of angiotensin production. Weakened vascular mechanisms and reduce aldosterone molten steel can be left to achieve the purpose of lowering blood pressure. In this paper, 43 cases of essential hypertension patients with enalapril capsules for treatment. To observe and explore the clinical efficacy and adverse reactions of enalapril in the treatment of essential hypertension,